HAVN Share Price Performance
CA$0
0.00 (0.00%)
Price CA$0
Share Pricen/a
HAVN Life Sciences Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
HAVN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
HAVN Life Sciences Inc. Key Details
Last Reported Earnings
Jan 31, 2023
Next Reporting Earnings
n/a
- -0.55
- 35.54%
- -2,676.59%
- 3.1%
About HAVN
- Founded
- 2020
- Employees
- n/a
- CEO
- WebsiteView website
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is based in Port Moody, Canada.
